SC 13G/A: Celldex Therapeutics, Inc.
Ticker: CLDX · Form: SC 13G/A · Filed: Nov 13, 2024 · CIK: 744218
| Field | Detail |
|---|---|
| Company | Celldex Therapeutics, Inc. (CLDX) |
| Form Type | SC 13G/A |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Celldex Therapeutics, Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Celldex Therapeutics, Inc. (ticker: CLDX) to the SEC on Nov 13, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
How long is this filing?
Celldex Therapeutics, Inc.'s SC 13G/A filing is 4 pages with approximately 1,332 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,332 words · 5 min read · ~4 pages · Grade level 10.3 · Accepted 2024-11-13 18:00:27
Filing Documents
- polar-cldx093024a1.htm (SC 13G/A) — 84KB
- 0001172661-24-004709.txt ( ) — 86KB
(a)Name of Issuer
Item 1. (a)Name of Issuer CELLDEX THERAPEUTICS, INC.
(b)Address of Issuer’s Principal
Item 1. (b)Address of Issuer’s Principal Executive Offices Perryville III Building 53 Frontage Road, Suite 220 Hampton, New Jersey 08827
(a)Name of Person Filing
Item 2. (a)Name of Person Filing: Polar Capital Holdings Plc Polar Capital LLP
(b,) Address of Principal Business Office
Item 2. (b,) Address of Principal Business Office: 16 Palace Street London, SW1E 5JD
(c)Citizenship
Item 2. (c)Citizenship: United Kingdom
(d)Title of Class of Securities
Item 2. (d)Title of Class of Securities Common Stock, par value $.001 (the “Shares”)
(e) CUSIP No
Item 2. (e) CUSIP No.: 15117B202 CUSIP No. 15117B202 Schedule 13G/A Page 5 of 8 Pages
If
Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 15117B202 Schedule 13G/A Page 6 of 8 Pages Item 4.Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1: Polar Capital Holdings Plc (a) Amount beneficially owned: 2,711,163 (b) Percent of class: 4.09%* (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 2,711,163 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,711,163 (iv) Shared power to dispose or to direct the disposition of: 0 Polar Capital LLP (a) Amount beneficially owned: 2,711,163 (b) Percent of class: 4.09%* (c) Number